“…Platelets are also considered to be an important mediator of detrimental events in graft failure, i.e., thrombogenesis, progressive intimal hyperplasia, and atherogenesis [28]. Srivastava [29] reported the ability of nifedipine, verapamil, and hydralazine to inhibit aggregation of human platelets in the presence of ADP, epinephrine, collagen, or arachidonate. Therefore, one might speculate that calcium antagonists reduce intimal thickness by inhibiting platelet aggregation stimulated by collagen exposed in the subendothelium after endotherial injury.…”